Cardiovascular Adverse Effects of Psychotropic Drugs
- 31 July 2020
- book chapter
- Published by Springer Nature
- p. 707-720
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Association of Stroke with the Receptor-Binding Profiles of Antipsychotics—A Case-Crossover StudyBiological Psychiatry, 2013
- Differential mortality rates in major and subthreshold depression: meta-analysis of studies that measured bothThe British Journal of Psychiatry, 2013
- Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophreniaBMC Psychiatry, 2012
- Cardiovascular Safety of One-Year Escitalopram Therapy in Clinically Nondepressed Patients With Acute Coronary SyndromeJournal of Cardiovascular Pharmacology, 2012
- Sudden Death of Cardiac Origin and Psychotropic DrugsFrontiers in Pharmacology, 2012
- Antipsychotic drugs and risk of pulmonary embolismPharmacoepidemiology and Drug Safety, 2011
- Ionic and Cellular Mechanisms Underlying the Development of Acquired Brugada Syndrome in Patients Treated with AntidepressantsJournal of Cardiovascular Electrophysiology, 2011
- Antipsychotic Pharmacotherapy and Orthostatic HypotensionCNS Drugs, 2011
- Review: Inequalities in healthcare provision for people with severe mental illnessJournal of Psychopharmacology, 2010
- Drug‐induced long QT syndrome: hERG K+channel block and disruption of protein trafficking by fluoxetine and norfluoxetineBritish Journal of Pharmacology, 2006